Literature DB >> 20477767

Polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and the blood and salivary ethanol and acetaldehyde concentrations of Japanese alcoholic men.

Akira Yokoyama1, Eri Tsutsumi, Hiromi Imazeki, Yoshihide Suwa, Chizu Nakamura, Tetsuji Yokoyama.   

Abstract

BACKGROUND: The effects of genetic polymorphism of aldehyde dehydrogenase-2 (ALDH2) on alcohol metabolism are striking in nonalcoholics, and the effects of genetic polymorphism of alcohol dehydrogenase-1B (ADH1B) are modest at most, whereas genetic polymorphisms of both strongly affect the susceptibility to alcoholism and upper aerodigestive tract (UADT) cancer of drinkers.
METHODS: We evaluated associations between ADH1B/ADH1C/ALDH2 genotypes and the blood and salivary ethanol and acetaldehyde levels of 168 Japanese alcoholic men who came to our hospital for the first time in the morning and had been drinking until the day before.
RESULTS: The ethanol levels in their blood and saliva were similar, but the acetaldehyde levels in their saliva were much higher than in their blood, probably because of acetaldehyde production by oral bacteria. Blood and salivary ethanol and acetaldehyde levels were both significantly higher in the subjects with the less active ADH1B*1/*1 genotype than in the ADH1B*2 carriers, but none of the levels differed according to ALDH2 genotype. Significant linkage disequilibrium was detected between the ADH1B and ADH1C genotypes, but ADH1C genotype did not affect the blood or salivary ethanol or acetaldehyde levels. High blood acetaldehyde levels were found even in the active ALDH2*1/*1 alcoholics, which were comparable with the levels of the inactive heterozygous ALDH2*1/*2 alcoholics with less active ADH1B*1/*1. The slope of the increase in blood acetaldehyde level as the blood ethanol level increased was significantly steeper in alcoholics with inactive heterozygous ALDH2*1/*2 plus ADH1B*2 allele than with any other genotype combinations, but the slopes of the increase in salivary acetaldehyde level as the salivary ethanol level increased did not differ between the groups of subjects with any combinations of ALDH2 and ADH1B genotypes.
CONCLUSIONS: The ADH1B/ALDH2 genotype affected the blood and salivary ethanol and acetaldehyde levels of nonabstinent alcoholics in a different manner from nonalcoholics, and clear effects of ADH1B genotype and less clear effects of ALDH2 were observed in the alcoholics. Alterations in alcohol metabolism as a result of alcoholism may modify the gene effects, and these findings provide some clues in regard to associations between the genotypes and the risks of alcoholism and UADT cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20477767     DOI: 10.1111/j.1530-0277.2010.01202.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  21 in total

1.  Alcohol dehydrogenase 1C (ADH1C) gene polymorphism and alcoholic liver cirrhosis risk: a meta analysis.

Authors:  Lei He; Tao Deng; He-Sheng Luo
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence.

Authors:  Akira Yokoyama; Nobuhito Taniki; Sachiko Hara; Emiko Haysashi; Nobuhiro Nakamoto; Takeshi Mizukami; Katsuya Maruyama; Tetsuji Yokoyama
Journal:  J Gastroenterol       Date:  2017-10-23       Impact factor: 7.527

3.  ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds.

Authors:  Koji Tanaka; Kelly A Whelan; Prasanna M Chandramouleeswaran; Shingo Kagawa; Sabrina L Rustgi; Chiaki Noguchi; Manti Guha; Satish Srinivasan; Yusuke Amanuma; Shinya Ohashi; Manabu Muto; Andres J Klein-Szanto; Eishi Noguchi; Narayan G Avadhani; Hiroshi Nakagawa
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

4.  Short-term salivary acetaldehyde increase due to direct exposure to alcoholic beverages as an additional cancer risk factor beyond ethanol metabolism.

Authors:  Dirk W Lachenmeier; Yulia B Monakhova
Journal:  J Exp Clin Cancer Res       Date:  2011-01-06

5.  Quantitative determination of acetaldehyde in foods using automated digestion with simulated gastric fluid followed by headspace gas chromatography.

Authors:  Michael Uebelacker; Dirk W Lachenmeier
Journal:  J Autom Methods Manag Chem       Date:  2011-06-13

6.  ADH1C Ile350Val polymorphism and cancer risk: evidence from 35 case-control studies.

Authors:  Yao Xue; Meilin Wang; Dongyan Zhong; Na Tong; Haiyan Chu; Xiaojing Sheng; Zhengdong Zhang
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.

Authors:  Akira Yokoyama; Philip J Brooks; Tetsuji Yokoyama; Takeshi Mizukami; Shunsuke Shiba; Nobuhiro Nakamoto; Katsuya Maruyama
Journal:  Jpn J Clin Oncol       Date:  2017-04-01       Impact factor: 3.019

8.  Association of ADH1B polymorphism and alcohol consumption with increased risk of intracerebral hemorrhagic stroke.

Authors:  Chun-Hsiang Lin; Oswald Ndi Nfor; Chien-Chang Ho; Shu-Yi Hsu; Disline Manli Tantoh; Yi-Chia Liaw; Mochly-Rosen Daria; Che-Hong Chen; Yung-Po Liaw
Journal:  J Transl Med       Date:  2021-05-29       Impact factor: 5.531

Review 9.  Prevention Strategies for Esophageal Cancer-An Expert Review.

Authors:  Elisa Marabotto; Gaia Pellegatta; Afscin Djahandideh Sheijani; Sebastiano Ziola; Patrizia Zentilin; Maria Giulia De Marzo; Edoardo Giovanni Giannini; Matteo Ghisa; Brigida Barberio; Marco Scarpa; Imerio Angriman; Matteo Fassan; Vincenzo Savarino; Edoardo Savarino
Journal:  Cancers (Basel)       Date:  2021-05-01       Impact factor: 6.639

10.  Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption.

Authors:  Shunsuke Shiba; Nobuhiro Nakamoto; Po-Sung Chu; Keisuke Ojiro; Nobuhito Taniki; Akihiro Yamaguchi; Rei Morikawa; Tadashi Katayama; Aya Yoshida; Ryo Aoki; Toshiaki Teratani; Takahiro Suzuki; Takeshi Miyamoto; Sachiko Hara; Akira Yokoyama; Takanori Kanai
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.